TORONTO, March 5, 2012 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) (the "Company") announced today that Mr. Steven Bloom has resigned as director of the Company. The Company wishes to express its gratitude to Mr. Bloom for his contributions.
About Biosign Technologies Inc.
Biosign Technologies Inc. (TSXV: BIO) provides biomedical systems. Key applications include intelligent systems for non-invasive monitoring of common health risks associated with blood pressure, lifestyle, and medication. The core technology combines measurement, analysis, and rapid knowledge formation to support health monitoring across global markets. The UFIT® medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation & management, and remote patient monitoring. For more information on Biosign, please visit www.biosign.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information:
Colley Clarke, CFO; Biosign Technologies Inc.: 416-218-9800, ext. 234